The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T, Maezawa Y, Hashimoto I, Hara K, Kazama K, Komori K, Kato A, Otani K, Tamagawa A, Cho H, Morita J, Kawahara S, Tanabe M, Oshima T, Saito A, Yukawa N, Rino Y.
Aoyama T, et al.
In Vivo. 2024 May-Jun;38(3):1253-1259. doi: 10.21873/invivo.13562.
In Vivo. 2024.
PMID: 38688590